Skip to content
Subscriber Only

SoftBank Backs Dog DNA Startup Embark at $700 Million Valuation

  • Firm aims to increase dog lifespans by three years this decade
  • CEO says its database will top 1 million dogs in coming months
The Sausage Dog Club Meets For Its Annual Walk In Bath

Photographer: Matt Cardy/Getty Images

Softbank Group Corp.’s Vision Fund 2 led a $75 million funding round for Embark Veterinary Inc., a genetics startup that seeks to increase dog lifespans.

The transaction values the Boston-based company at $700 million, Embark Chief Executive Officer Ryan Boyko said in an interview.